6-70861961-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The ENST00000230053.11(B3GAT2):ā€‹c.754C>Gā€‹(p.Gln252Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 6.9e-7 ( 0 hom. )

Consequence

B3GAT2
ENST00000230053.11 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.00
Variant links:
Genes affected
B3GAT2 (HGNC:922): (beta-1,3-glucuronyltransferase 2) The product of this gene is a transmembrane protein belonging to the glucuronyltransferase family, and catalyzes the transfer of a beta-1,3 linked glucuronic acid to a terminal galactose in different glycoproteins or glycolipids containing a Gal-beta-1-4GlcNAc or Gal-beta-1-3GlcNAc residue. The encoded protein is involved in the synthesis of the human natural killer-1 (HNK-1) carbohydrate epitope, a sulfated trisaccharide implicated in cellular migration and adhesion in the nervous system. [provided by RefSeq, Jul 2008]
SMAP1 (HGNC:19651): (small ArfGAP 1) The protein encoded by this gene is similar to the mouse stromal membrane-associated protein-1. This similarity suggests that this human gene product is also a type II membrane glycoprotein involved in the erythropoietic stimulatory activity of stromal cells. Alternate splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.32764387).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
B3GAT2NM_080742.3 linkuse as main transcriptc.754C>G p.Gln252Glu missense_variant 3/4 ENST00000230053.11 NP_542780.1
SMAP1NM_001044305.3 linkuse as main transcriptc.*1627G>C 3_prime_UTR_variant 11/11 ENST00000370455.8 NP_001037770.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
B3GAT2ENST00000230053.11 linkuse as main transcriptc.754C>G p.Gln252Glu missense_variant 3/41 NM_080742.3 ENSP00000230053 P1
B3GAT2ENST00000615536.1 linkuse as main transcriptc.538C>G p.Gln180Glu missense_variant 3/41 ENSP00000481320
SMAP1ENST00000370455.8 linkuse as main transcriptc.*1627G>C 3_prime_UTR_variant 11/111 NM_001044305.3 ENSP00000359484 P3Q8IYB5-1
SMAP1ENST00000619054.4 linkuse as main transcriptc.*1627G>C 3_prime_UTR_variant 11/111 ENSP00000484538

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000401
AC:
1
AN:
249346
Hom.:
0
AF XY:
0.00000742
AC XY:
1
AN XY:
134758
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000546
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.86e-7
AC:
1
AN:
1458788
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
725400
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000253
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 18, 2024The c.754C>G (p.Q252E) alteration is located in exon 3 (coding exon 3) of the B3GAT2 gene. This alteration results from a C to G substitution at nucleotide position 754, causing the glutamine (Q) at amino acid position 252 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.28
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T;.
Eigen
Benign
0.016
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.84
T;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.33
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.1
L;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-1.3
N;.
REVEL
Benign
0.087
Sift
Benign
0.21
T;.
Sift4G
Benign
0.42
T;T
Polyphen
0.045
B;.
Vest4
0.35
MutPred
0.46
Loss of MoRF binding (P = 0.0574);.;
MVP
0.72
MPC
0.63
ClinPred
0.43
T
GERP RS
5.5
Varity_R
0.36
gMVP
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs771270674; hg19: chr6-71571664; API